111

JACOBIO PHARMACEUTICALS GRP CO LTD

No trades
See on Supercharts
Market capitalization
‪1.15 B‬HKD
−0.51HKD
‪−396.83 M‬HKD
‪70.19 M‬HKD
‪493.12 M‬
Beta (1Y)
1.76

About JACOBIO PHARMACEUTICALS GRP CO LTD

CEO
Yin Xin Wang
Headquarters
Beijing
Employees (FY)
301
Founded
2018
ISIN
KYG4987A1094
FIGI
BBG00YGD1105
Jacobio Pharmaceuticals Group Co., Ltd. is an investment holding company, which engages in the research and development of pharmaceutical products. The company was founded on June 01, 2018 and is headquartered in Beijing, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 1167 is 1.46 HKD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange JACOBIO PHARMACEUTICALS GRP CO LTD stocks are traded under the ticker 1167.
JACOBIO PHARMACEUTICALS GRP CO LTD is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
1167 stock is 9.86% volatile and has beta coefficient of 1.76. Check out the list of the most volatile stocks — is JACOBIO PHARMACEUTICALS GRP CO LTD there?
1167 earnings for the last quarter are −0.24 HKD per share, whereas the estimation was −0.31 HKD resulting in a 24.14% surprise. The estimated earnings for the next quarter are −0.30 HKD per share. See more details about JACOBIO PHARMACEUTICALS GRP CO LTD earnings.
JACOBIO PHARMACEUTICALS GRP CO LTD revenue for the last quarter amounts to ‪43.59 M‬ HKD despite the estimated figure of ‪32.42 M‬ HKD. In the next quarter revenue is expected to reach ‪21.63 M‬ HKD.
Yes, you can track JACOBIO PHARMACEUTICALS GRP CO LTD financials in yearly and quarterly reports right on TradingView.
1167 stock has fallen by 8.18% compared to the previous week, the month change is a 20.22% fall, over the last year JACOBIO PHARMACEUTICALS GRP CO LTD has showed a 79.92% decrease.
1167 net income for the last quarter is ‪−208.33 M‬ HKD, while the quarter before that showed ‪−188.06 M‬ HKD of net income which accounts for −10.78% change. Track more JACOBIO PHARMACEUTICALS GRP CO LTD financial stats to get the full picture.
Today JACOBIO PHARMACEUTICALS GRP CO LTD has the market capitalization of ‪1.16 B‬, it has increased by 10.76% over the last week.
No, 1167 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 1167 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JACOBIO PHARMACEUTICALS GRP CO LTD stock right from TradingView charts — choose your broker and connect to your account.
1167 reached its all-time high on Feb 4, 2021 with the price of 25.35 HKD, and its all-time low was 1.38 HKD and was reached on Apr 19, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 23, 2024, the company has 301.00 employees. See our rating of the largest employees — is JACOBIO PHARMACEUTICALS GRP CO LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JACOBIO PHARMACEUTICALS GRP CO LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JACOBIO PHARMACEUTICALS GRP CO LTD stock shows the sell signal. See more of JACOBIO PHARMACEUTICALS GRP CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on JACOBIO PHARMACEUTICALS GRP CO LTD future price: according to them, 1167 price has a max estimate of 7.62 HKD and a min estimate of 4.28 HKD. Read a more detailed JACOBIO PHARMACEUTICALS GRP CO LTD forecast: see what analysts think of JACOBIO PHARMACEUTICALS GRP CO LTD and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JACOBIO PHARMACEUTICALS GRP CO LTD EBITDA is ‪−432.67 M‬ HKD, and current EBITDA margin is −615.01%. See more stats in JACOBIO PHARMACEUTICALS GRP CO LTD financial statements.